, Volume 7, Issue 1, pp 63–68 | Cite as

The anti-inflammatory properties of rose-hip

  • K. Winther
  • E. Rein
  • A. Kharazmi
Short Communication


Abstract-The anti-inflammatory properties of rose-hip are described in this short report. Rose-hip extract reduced chemotaxis of peripheral blood neutrophils and monocytes of healthy subjects in vitro. Daily intake of rose-hip powder for four weeks by healthy volunteers and patients suffering from osteoarthritis, resulted in reduced serum C-reactive protein (CRP) levels and reduced chemotaxis of peripheral blood neutrophils. The results indicate that rose-hip possesses anti-inflammatory properties and might be used as a replacement or supplement for conventional drug therapies in patients with osteoarthritis.

Key words

rose-hip osteoarthritis anti-inflammatory chemotaxis CRP 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    K. Winther, A. Kharazmi and B. Rangaard (1997). Cell preserving and antiinflammatory property of rose-hip (Hyben Vital). Possible clinical implication, 1st. Int. Congress on Coronary Artery Diseases: From prevention to intervention, pp. 68. Prague, Czech Republic.Google Scholar
  2. 2.
    P. Jensen and A. Kharazmi (1991). Computer-assisted image analysis assay of human neutrophil chemotaxis in vitro, J. Immunol. Method 144, 43–48.CrossRefGoogle Scholar
  3. 3.
    A. Leung and S. Foster (1996). Encyclopedia of Common Natural Ingredients. John Wiley, New York.Google Scholar
  4. 4.
    P. M. Ridker, M. Cushman, M. J. Stampfer, R. P. Tracey and C. H. Hennekens (1997). Inflammation, aspirin and the risk of cardiovascular diseases in apparently healthy men, New Eng. J. Med. 336, 973–979.PubMedCrossRefGoogle Scholar
  5. 5.
    E. D. Harris, Jr. (1988). Pathogenesis of rheumatoid arthritis: A disorder associated with dysfunctional immunoregulation, in: Inflammation: Basic principles and clinical correlates, J. H. Gallin, I. M. Goldstein and R. Snyderman (Eds), pp. 751–773. Raven Press, New York.Google Scholar
  6. 6.
    M. C. Hochberger, R. D. Altaian, K. D. Brandt, B. M. Clarck, P. A. Dieppe, M. R. Griffin, R. W. Moskowitz and T. J. Schnitzer (1995). Guidelines for the medical management of osteoarthritis (part one), Arthritis Rheum. 38, 1535–1540.CrossRefGoogle Scholar
  7. 7.
    M. C. Hochberger, R. D. Altman, K. D. Brandt, B. M. Clarck, P. A. Dieppe, M. R. Griffin, R. W. Moskowitz and T. J. Schnitzer (1995). Guidelines for the medical management of osteoarthritis (part two), Arthritis Rheum. 38, 1541 -1546.CrossRefGoogle Scholar
  8. 8.
    Y. Matzner, R. Drexler and M. Levy (1984). Effect of dipyrone, acetylsalicylic acid and acetaminophen on human neutrophil chemotaxis, Eur. J. Clin. Invest. 14, 440–443.PubMedCrossRefGoogle Scholar
  9. 9.
    A. Kemp and J. Smith (1987). The effect of salicylate on human leukocyte migration, Clin. Exp. Immunol. 49, 233–238.Google Scholar
  10. 10.
    I. Rivkin, V. Foschi and C. H. Rosen (1976). Inhibition of in vitro neutrophil chemotaxis and spontaneous motility by anti-inflammatory agents (39518), Proc. Soc. Exp. Biol. Med. 153, 236–240.PubMedGoogle Scholar
  11. 11.
    H. B. Kaplan, H. S. Edelson, H. M. Korchak, W. P. Given, S. Abramson and G. Weismann (1984). Effect of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo, Biochem. Pharmacol. 33, 371–378.PubMedCrossRefGoogle Scholar
  12. 12.
    E. G. Maderazo, S. P. Breaux and C. L. Woronick (1984). Inhibition of human polymorphonuclear leukocyte cell response by ibuprofen, J. Pharm. Sci. 73, 1403–1406.PubMedCrossRefGoogle Scholar

Copyright information

© VSP 1999

Authors and Affiliations

  • K. Winther
    • 1
  • E. Rein
    • 1
  • A. Kharazmi
    • 2
  1. 1.Department of Clinical ChemistryKolding HospitalHoldingDenmark
  2. 2.Department of Clinical MicrobiologyUniversity Hospital (Rigshospitalet)CopenhagenDenmark

Personalised recommendations